KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Cash & Current Investments (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Cash & Current Investments for 15 consecutive years, with $308.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Current Investments fell 31.95% to $308.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $308.7 million, a 31.95% decrease, with the full-year FY2025 number at $308.7 million, down 31.95% from a year prior.
  • Cash & Current Investments was $308.7 million for Q4 2025 at Supernus Pharmaceuticals, up from $281.2 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $522.6 million in Q2 2025 to a low of $151.7 million in Q2 2023.
  • A 5-year average of $351.2 million and a median of $354.0 million in 2022 define the central range for Cash & Current Investments.
  • Peak YoY movement for Cash & Current Investments: tumbled 57.97% in 2023, then surged 128.93% in 2024.
  • Supernus Pharmaceuticals' Cash & Current Investments stood at $339.7 million in 2021, then surged by 35.81% to $461.3 million in 2022, then crashed by 44.75% to $254.9 million in 2023, then skyrocketed by 77.97% to $453.6 million in 2024, then tumbled by 31.95% to $308.7 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Cash & Current Investments are $308.7 million (Q4 2025), $281.2 million (Q3 2025), and $522.6 million (Q2 2025).